natgillin/translations-raw huggingface dataset:
For doses in the interval of 0.2-0.4 units/kg (U/kg), Levemir exerts more than 50% of its maximum effect from 3-4 hours and up to approximately 14 hours after dose administration. 
V odmerkih zdravila Levemir v območju od 0,2-0,4 enot/kg (e./kg) znaša trajanje učinka, večjega od 50 % največjega učinka, od 3-4 ur do približno 14 ur po apliciranju odmerka.
Diabetic retinopathy (an eye disease related to diabetes which can lead to loss of vision): If you have diabetic retinopathy and your blood sugar level improves very fast, the retinopathy may get worse. 
Diabetična retinopatija (s sladkorno boleznijo povezana bolezen oči, ki lahko povzroči izgubo vida): če imate diabetično retinopatijo in se vam koncentracija krvnega sladkorja zelo hitro izboljša, se vam lahko retinopatija poslabša.
Concomitant antidiabetic treatment may need to be adjusted (dose and/or timing of oral antidiabetic medicinal products or concurrent short/rapid-acting insulin medicinal products). 
Spremljajoče zdravljenje sladkorne bolezni je morda treba prilagoditi (odmerek in/ali čas uporabe peroralnih antidiabetikov ali dajanja sočasno uporabljenih kratko-/hitrodelujočih insulinskih zdravil).
Serious allergic reaction to Levemir or one of its ingredients (called a systemic allergic reaction) is a very rare side effect but can potentially be life threatening. 
Resna alergijska reakcija na zdravilo Levemir ali katero od njegovih sestavin (to imenujemo sistemska alergijska reakcija) je zelo redek, a potencialno smrtno nevaren neželeni učinek.
Results indicate that antibody development had no negative effect on glycaemic control and Levemir dose. 
Rezultati kažejo, da pojav protiteles nima negativnega vpliva na urejenost glikemije in odmerek zdravila Levemir.
What you need to know before you use Levemir 
Kaj morate vedeti, preden boste uporabili zdravilo Levemir
To see precisely how much insulin is left use the dose counter: Turn the dose selector until the dose counter stops. 
Če želite videti, koliko insulina je še ostalo, uporabite števec odmerka: Vrtite izbirnik odmerka dokler se števec odmerka ne ustavi.
• Severe hypoglycaemic episodes, where the patient has become unconscious, can be treated with glucagon (0.5 to 1 mg) given intramuscularly or subcutaneously by a trained person, or with glucose given intravenously by a healthcare professional. 
• Hude hipoglikemije, ko je bolnik nezavesten, je mogoče zdraviti z glukagonom (0,5 do 1 mg), ki ga da intramuskularno ali subkutano ustrezno podučena oseba, ali z glukozo, ki jo da intravensko zdravstveni delavec.
Efficacy and safety data for adolescent patients with type 2 diabetes mellitus have been extrapolated from data for children, adolescent and adult patients with type 1 diabetes mellitus and adult patients with type 2 diabetes mellitus. 
Podatki o učinkovitosti in varnosti za mladostnike s sladkorno boleznijo tipa 2 so ekstrapolirani iz podatkov, pridobljenih pri otrocih, mladostnikih in odraslih s sladkorno boleznijo tipa 1 ter odraslih s sladkorno boleznijo tipa 2.
The trial started with a 12-week run-in period with liraglutide+metformin, where 61% reached an HbA1c <7%. 
Začelo se je z 12-tedenskim obdobjem uvajanja s kombinacijo liraglutid + metformin; med tem obdobjem je 61 % preiskovancev doseglo HbA1c < 7 %.
When the pen is empty, throw it away without a needle on as instructed by your doctor, nurse, pharmacist or local authorities. 
Ko je peresnik prazen, ga pazljivo zavrzite brez nameščene igle, kot vam je to naročil vaš zdravnik, medicinska sestra ali farmacevt, v skladu z lokalnimi predpisi.
Randomised liraglutide + metformin n=149 
metformin n = 149
1 unit insulin detemir corresponds to 1 international unit of human insulin. 
Ena enota insulina detemir ustreza 1 mednarodni enoti humanega insulina.
• Sympathomimetics (such as epinephrine [adrenaline], or salbutamol, terbutaline used to treat asthma) 
• simpatikomimetike (na primer adrenalin, salbutamol, terbutalin, uporabljajo se za zdravljenje astme),
In general, intensified blood glucose control and monitoring of pregnant women with diabetes are recommended throughout pregnancy and when contemplating pregnancy. 
Na splošno sta pri ženskah s sladkorno boleznijo med celotno nosečnostjo in pred nameravano nosečnostjo priporočljiva intenzivnejša kontrola glukoze v krvi in spremljanje nosečnice.
When transferring from other intermediate or long-acting insulin medicinal products, adjustment of the dose and timing of administration may be necessary (see section 4.4). 
Pri prehodu z drugih srednjedolgodelujočih ali dolgodelujočih insulinskih zdravil je lahko potrebna prilagoditev odmerka in časa apliciranja (glejte poglavje 4.4).
What Levemir is and what it is used for 
Kaj je zdravilo Levemir in za kaj ga uporabljamo
• After the injection, the needle should remain under the skin for at least 6 seconds to ensure that the full dose has been delivered. 
• Po injiciranju mora igla ostati pod kožo vsaj 6 sekund, da je zanesljivo vbrizgan celotni odmerek.
The time action profile of Levemir is statistically significantly less variable and therefore more predictable than for NPH (Neutral Protamine Hagedorn) insulin as seen from the within-subject Coefficients of Variation (CV) for the total and maximum pharmacodynamic effect in Table 1. 
Časovni potek delovanja zdravila Levemir je statistično pomembno manj spremenljiv in zato bolj predvidljiv kot časovni potek delovanja insulina NPH (nevtralni protamin Hagedorn), kar je razvidno iz Preglednice 1, ki prikazuje koeficiente spremenljivosti (CV, Coefficient of Variation) za celotni in največji farmakodinamični učinek.
Levemir provides up to 24 hours of basal insulin coverage. 
Zdravilo Levemir zagotavlja do 24-urno kritje bazalnega insulina.
Continuous rotation of the injection site within a given area may help to reduce or prevent these reactions. 
Stalno krožno menjavanje mest injiciranja na posameznem predelu pomaga zmanjšati ali preprečiti te reakcije.
Addition of Levemir provided a further reduction of HbA1c from 7.6% to 7.1% after 52 weeks. 
Dodatek zdravila Levemir je po 52 tednih prinesel dodatno znižanje HbA1c s 7,6 % na 7,1 %.
What to do if you experience high blood sugar: ► If you get any of above signs: test your blood sugar level, test your urine for ketones if you can, then seek medical advice immediately. 
Kaj narediti, če se vam pojavi visok krvni sladkor ► Če se pojavi kateri od zgoraj omenjenih znakov, si izmerite sladkor v krvi, določite ketone v urinu, če imate to možnost, potem pa takoj poiščite zdravniški nasvet.
There were no major hypoglycaemic episodes. 
Hudih hipoglikemij ni bilo.
Animal studies do not indicate harmful effects with respect to fertility. 
Plodnost Študije na živalih ne kažejo neželenih učinkov na plodnost.
Post-marketing data from an additional 250 outcomes from pregnant women exposed to Levemir indicate no adverse effects of insulin detemir on pregnancy and no malformative or foetal/neonatal toxicity of insulin detemir. 
Podatki po prihodu zdravila na trg o dodatnih 250 izidih pri nosečnicah, izpostavljenih zdravilu Levemir, ne kažejo neželenih učinkov insulina detemir na nosečnost in tudi ne malformacijskih učinkov ali toksičnih učinkov insulina detemir na plod oz. novorojenčka.
You can carry it with you and keep it at room temperature (below 30°C) for up to 6 weeks. 
S seboj ga lahko nosite in shranjujete pri sobni temperaturi (do 30 °C) do 6 tednov.
On rare occasions, injection site reactions may require discontinuation of Levemir. 
V redkih primerih lahko reakcije na mestu injiciranja zahtevajo prekinitev zdravljenja z zdravilom Levemir.
GIRmax** *Area under the curve ** Glucose Infusion Rate p-value <0.001 for all comparisons with Levemir 
* Površina pod krivuljo ** Hitrost infuzije glukoze p-vrednost < 0,001 za vse primerjave z zdravilom
Substances added to Levemir may cause degradation of insulin detemir, e.g. if the medicinal product contains thiols or sulphites. 
Dodajanje snovi zdravilu Levemir bi lahko povzročilo razgradnjo insulina detemir, npr. če zdravilo vsebuje tiole ali sulfite.
When adjusting dose in order to improve glucose control, patients should be advised to be aware of signs of hypoglycaemia. 
V primeru prilagajanja odmerka za izboljšanje urejenosti koncentracije glukoze v krvi je bolnike treba opozoriti, da morajo biti pozorni na znake hipoglikemije.
After an increase in insulin antibodies during the first year, the insulin antibodies decreased during the second year to a level slightly higher than pre-trial level. 
Po porastu protiteles proti insulinu med prvim letom so ta med drugim letom upadla na raven, rahlo višjo od ravni pred preskušanjem.
OTHER Novo Nordisk A/S 
Novo Nordisk A/S,
Levemir must not be administered intravenously, as it may result in severe hypoglycaemia. 
Zdravila Levemir se ne sme aplicirati intravensko, ker lahko povzroči hudo hipoglikemijo.
• The active substance is insulin detemir. 
• Zdravilna učinkovina je insulin detemir.
When Levemir is used in combination with oral antidiabetic medicinal products or when added to GLP-1 receptor agonists it is recommended to use Levemir once daily, initially at a dose of 0.10.2 units/kg or of 10 units in adult patients. 
Če se zdravilo Levemir uporablja v kombinaciji s peroralnimi antidiabetiki ali se ga doda k zdravljenju z agonistom receptorjev GLP-1, je zdravilo Levemir priporočljivo uporabljati enkrat na dan, uvodoma z odmerkom 0,1-0,2 enoti/kg ali z odmerkom 10 enot pri odraslih bolnikih.
Levemir has a long and steady blood-sugar-lowering action within 3 to 4 hours after injection. 
Zdravilo Levemir dolgotrajno in enakomerno znižuje krvni sladkor; ta učinek se začne v 3 do 4 urah po injiciranju.
Degradation of insulin detemir is similar to that of human insulin; all metabolites formed are inactive. 
Razgradnja insulina detemir je podobna razgradnji humanega insulina - vsi nastali presnovki so neaktivni.
The number of live born children of women becoming pregnant after randomisation were 50 (83%) for Levemir and 55 (89%) for NPH. 
Število živorojenih otrok je bilo pri ženskah, ki so zanosile po randomizaciji, 50 (83 %) v skupini z zdravilom Levemir in 55 (89 %) v skupini z insulinom NPH.
► If you are breast-feeding consult your doctor as you may require adjustments in your insulin doses. 
► Če dojite, se posvetujte s svojim zdravnikom, saj morda potrebujete prilagoditev odmerka insulina.
Injection site reactions are seen more frequently during treatment with Levemir than with human insulin products. 
Reakcije na mestu injiciranja so med zdravljenjem z zdravilom Levemir pogostejše kot med zdravljenjem z zdravili s humanim insulinom.
In the study versus insulin glargine, Levemir was allowed to be administered once or twice daily whereas insulin glargine was to be administered once a day, 55% of the Levemir treated patients completed the 52 weeks of treatment on the twice daily regimen. 
V študiji, ki je primerjala insulin glargin in zdravilo Levemir, so bolniki zdravilo Levemir lahko aplicirali enkrat ali dvakrat na dan, insulin glargin pa so morali aplicirati enkrat na dan; 55 % bolnikov, ki so dobivali zdravilo Levemir, je 52-tedensko zdravljenje dokončalo z uporabo dvakrat na dan.
Patients transferred to Levemir from another type of insulin may require a change in dose from that used with their usual insulin medicinal products. 
Bolniki, ki preidejo na zdravilo Levemir z druge vrste insulina, bodo morda morali spremeniti odmerek, ki so se ga držali pri običajnih insulinskih zdravilih.
Levemir FlexPen/Levemir InnoLet/Levemir FlexTouch 1 ml of the solution contains 100 units insulin detemir* (equivalent to 14.2 mg). 
Levemir FlexPen/Levemir InnoLet/Levemir FlexTouch 1 ml raztopine vsebuje 100 enot insulina detemir* (kar ustreza 14,2 mg).
► If you have such low blood sugar that makes you pass out, if you have had the need for an injection of glucagon, or if you have experienced many incidents of low blood sugar, talk to a doctor. 
► Če imate tako nizek krvni sladkor, da se onesvestite, če ste morali dobiti injekcijo glukagona ali če ste velikokrat imeli nizek krvni sladkor, se posvetujte z zdravnikom.
The results of the in vitro and in vivo protein binding studies suggest that there is no clinically relevant interaction between insulin detemir and fatty acids or other protein bound medicinal products. 
Rezultati študij vezave na beljakovine in vitro ter in vivo so pokazali, da med insulinom detemir in maščobnimi kislinami ali drugimi zdravili, ki se vežejo na beljakovine, ni klinično pomembnih interakcij.
If administered twice daily, steady state will occur after 2-3 dose administrations. 
Če apliciramo dvakrat dnevno, bo stanje dinamičnega ravnovesja doseženo po 2-3 apliciranjih odmerka.
The occurrence of generalised hypersensitivity reactions (including generalised skin rash, itching, sweating, gastrointestinal upset, angioneurotic oedema, difficulties in breathing, palpitation and reduction in blood pressure) is very rare but can potentially be life threatening. 
Pojav generaliziranih preobčutljivostnih reakcij (med drugim generalizirani izpuščaj na koži, srbenje, znojenje, prebavne motnje, angionevrotični edem, težko dihanje, palpitacije in znižanje krvnega tlaka) je zelo redek, vendar je lahko smrtno nevaren.
In these patients, addition of liraglutide resulted in a greater decline in HbA1c compared to addition of placebo (to 6.93% vs. to 8.24%), a greater decline in fasting plasma glucose (to 7.20 mmol/l vs. to 8.13 mmol/l), and a greater decline in body weight (-3.47 kg vs. -0.43 kg). 
Dodatek liraglutida je v primerjavi z dodatkom placeba povzročil večje zmanjšanje vrednosti HbA1c (do 6,93 % v primerjavi z do 8,24 %), večje zmanjšanje vrednosti glukoze v plazmi na tešče (do 7,20 mmol/l v primerjavi z do 8,13 mmol/l) in večje zmanjšanje telesne mase (-3,47 kg v primerjavi z -0,43 kg).
If your blood sugar is low or high, it might affect your concentration and ability to react and therefore also your ability to drive a car or operate a machine. Bear in mind that you could endanger yourself or others. 
Če imate visok ali nizek krvni sladkor, se vam zbranost in sposobnost reagiranja lahko spremenita, s tem pa tudi vaša sposobnost za upravljanje vozil in strojev.
The dose of Levemir should be titrated based on the individual patient's needs. 
Odmerek zdravila Levemir je treba titrirati glede na potrebe posameznega bolnika.
Adverse reactions observed in patients using Levemir are mainly due to the pharmacologic effect of insulin. 
Neželeni učinki, opaženi pri bolnikih, ki uporabljajo zdravilo Levemir, so zlasti posledica farmakološkega učinka insulina.
• Always carry an extra pen and new needles with you, in case of loss or damaged. 
• Vedno nosite s seboj rezervni injekcijski peresnik in nove igle, če jih izgubite ali se poškodujejo.
In trials investigating the use of oral antidiabetic medicinal products, combination therapy with Levemir resulted in a 61-65% lower risk of minor nocturnal hypoglycaemia compared to NPH insulin. 
V preskušanjih, v katerih so raziskovali uporabo peroralnih antidiabetikov, je bilo kombinirano zdravljenje z zdravilom Levemir povezano z 61-65 % manjšim tveganjem za blage nočne hipoglikemije kot kombinirano zdravljenje z insulinom NPH.
Some medicines affect your blood sugar level and this may mean that your insulin dose has to change. 
Nekatera zdravila vplivajo na delovanje krvnega sladkorja v telesu in lahko tako vplivajo na vaš odmerek insulina.
• Deliver the dose by pressing the push-button fully down (picture D). 
• Odmerek vbrizgajte tako, da potisni gumb pritisnete do konca (slika D).
There were no clinically relevant differences in pharmacokinetic properties between young children, children, adolescents and adults. 
Farmakokinetične lastnosti se med mlajšimi otroci, otroci, mladostniki in odraslimi niso klinično pomembno razlikovale.
When Levemir is used as part of a basal-bolus insulin regimen Levemir should be administered once or twice daily depending on patients' needs. 
Če je zdravilo Levemir uporabljeno kot del bazalno-bolusne sheme zdravljenja z insulinom, ga je treba aplicirati enkrat ali dvakrat na dan, odvisno od bolnikovih potreb.
Levemir can be used alone as the basal insulin or in combination with bolus insulin. 
Zdravilo Levemir je mogoče uporabljati sàmo, kot bazalni insulin, ali v kombinaciji z bolusnim insulinom.
• your doctor has switched you from one type or brand of insulin to another, or 
• eno vrsto ali znamko insulina zamenja z drugo, ali
Clinical trial data - Levemir add-on to liraglutide+metformin Study week Randomised 
Podatki kliničnega preskušanja - dodatek zdravila Levemir kot dodatno zdravljenje h kombinaciji liraglutid + metformin Teden študije
+8 units 
+ 8 enot
No metabolic effects of ingested insulin detemir on the breast-fed newborn/infant are anticipated since insulin detemir, as a peptide, is digested into amino acids in the human gastrointestinal tract. 
Presnovnih učinkov zaužitega insulina detemir na dojenega novorojenčka/dojenčka ni pričakovati, ker se insulin detemir kot peptid v človeških prebavilih prebavi v aminokisline.
Levemir is not to be used in insulin infusion pumps. 
Zdravila Levemir se ne sme uporabljati v infuzijskih črpalkah za insulin.
Dose proportionality in pharmacodynamic response (maximum effect, duration of action, total effect) is observed after subcutaneous administration. 
Pri subkutanem apliciranju so farmakodinamične lastnosti (največji učinek, trajanje delovanja, celotni učinek) odvisne od odmerka.
Levemir is a modern insulin (insulin analogue) with a long-acting effect. 
Zdravilo Levemir je sodobni insulin (insulinski analog) z dolgotrajnim delovanjem.
Rare side effects May affect less than 1 in 1,000 people. 
Redki neželeni učinki Pojavijo se lahko pri manj kot 1 od 1.000 bolnikov.
Insert the needle into your skin as your doctor or nurse has shown you. 
Iglo zabodite v kožo tako, kot sta vam pokazala zdravnik ali medicinska sestra.
Uncommon - Allergic reactions, potentially allergic reactions, urticaria, rash, eruptions* 
Občasno - alergijske reakcije, potencialne alergijske reakcije, urtikarija, izpuščaj, erupcije*
• Hold InnoLet with the needle upwards and tap the cartridge gently with your finger a few times (picture B) to make any air bubbles collect at the top of the cartridge. 
• Držite injekcijski peresnik InnoLet tako, da je igla obrnjena navzgor, in s prstom nekajkrat rahlo potrkajte po vložku (slika B), da se bodo zračni mehurčki zbrali na vrhu vložka.
Results support the use of Levemir in adolescent patients with type 2 diabetes mellitus. 
Rezultati podpirajo uporabo zdravila Levemir pri mladostnikih s sladkorno boleznijo tipa 2.
A major hypoglycaemic episode is defined as an episode where the subject was not able to treat him/herself and if glucagon or i.v. 
Huda hipoglikemija je opredeljena kot hipoglikemija, pri kateri si preiskovanec ni mogel pomagati sam in je bilo potrebno aplicirati glukagon ali intravensko glukozo.
In case of hypoglycaemia or if hypoglycaemia is suspected, Levemir must not be injected. 
V primeru hipoglikemije ali suma na hipoglikemijo se zdravila Levemir ne sme injicirati.
Insulin detemir is distributed more slowly to peripheral target tissues compared to NPH insulin. 
Insulin detemir se v primerjavi z insulinom NPH počasneje porazdeli v periferna ciljna tkiva.
When changing basal insulin to Levemir, dose reduction of basal and bolus insulin needs to be considered on an individual basis, in order to minimise the risk of hypoglycaemia (see section 4.4). 
Pri zamenjavi bazalnega insulina z zdravilom Levemir je pri vsakem bolniku posebej treba presoditi o zmanjšanju odmerka bazalnega in bolusnega insulina, da se zmanjša tveganje za pojav hipoglikemije (glejte poglavje 4.4).
The following substances may reduce the patient's insulin requirements: Oral antidiabetic medicinal products, GLP-1 receptor agonists, monoamine oxidase inhibitors (MAOI), beta-blockers, angiotensin converting enzyme (ACE) inhibitors, salicylates, anabolic steroids and sulphonamides. 
Bolnikovo potrebo po insulinu lahko zmanjšajo naslednje snovi: peroralni antidiabetiki, agonisti receptorjev GLP-1, zaviralci monoaminooksidaze (MAO), zaviralci adrenergičnih receptorjev beta, zaviralci angiotenzinske konvertaze (ACE), salicilati, anabolni steroidi in sulfonamidi.
F. Turn the dose selector to select 2 units. 
F. Zavrtite izbirnik odmerka tako, da boste izbrali 2 enoti.
These combined mechanisms of protraction provide a more reproducible absorption and action profile of insulin detemir compared to NPH insulin. 
Kombinirani mehanizmi vleka zagotavljajo enakomernejšo absorpcijo in potek delovanja insulina detemir v primerjavi z insulinom NPH.
Levemir contains less than 1 mmol sodium (23 mg) per dose, i.e. Levemir is essentially ‘sodium-free'. 
Pomembne informacije o nekaterih sestavinah zdravila Levemir Zdravilo Levemir vsebuje manj kot 1 mmol (23 mg) natrija na odmerek, kar v bistvu pomeni ‘brez natrija'.
• Glucocorticoids (such as ‘cortisone' used to treat inflammation) 
• glukokortikoide (na primer "kortizon", uporabljajo se za zdravljenje vnetja),
MARKETING AUTHORISATION NUMBER EU/1/04/278/014 
ŠTEVILKA DOVOLJENJA ZA PROMET EU/1/04/278/014
EXP During use: Use within 6 weeks 
Uporabno do/ Med uporabo: porabite v 6 tednih.
For patients who require twice daily dosing to optimise blood sugar control, the evening dose can be administered in the evening or at bedtime. 
Bolnikom, ki zaradi boljšega uravnavanja krvnega sladkorja potrebujejo odmerjanje dvakrat dnevno, je mogoče večerni odmerek aplicirati zvečer ali pred spanjem.
Subsequently, patients were allowed to up-titrate their insulin dose to no higher than the pre-randomisation dose. 
Kasneje so bolniki odmerek insulina lahko znova zvišali, vendar največ do odmerka pred randomizacijo.
Concomitant diseases in the kidney, liver or affecting the adrenal, pituitary or thyroid gland can require changes in insulin dose. 
Sočasne bolezni ledvic, jeter ali nadledvične žleze, hipofize ali ščitnice lahko zahtevajo spremembo odmerka insulina.
When administered twice daily, steady state serum concentrations are reached after 2-3 dose administrations. 
Če apliciramo dvakrat dnevno, bodo koncentracije v serumu v stanju dinamičnega ravnovesja dosežene po 2-3 odmerkih.
Combination of Levemir with pioglitazone 
Kombinacija zdravila Levemir in pioglitazona
In treatment of type 2 diabetes mellitus, Levemir may also be used in combination with tablets for diabetes and/or with injectable anti-diabetic products, other than insulin. 
Pri zdravljenju sladkorne bolezni tipa 2 se zdravilo Levemir lahko uporablja tudi v kombinaciji s tabletami za zdravljenje sladkorne bolezni in/ali neinsulinskimi zdravili za zdravljenje sladkorne bolezni za injiciranje.
• Always make sure that a drop appears at the needle tip before injection (picture B). 
• Pred injiciranjem vedno preverite, da se je na konici igle pojavila kapljica (slika B).
What Levemir is and what it is used for What you need to know before you use Levemir How to use Levemir 
Kaj je zdravilo Levemir in za kaj ga uporabljamo Kaj morate vedeti, preden boste uporabili zdravilo Levemir Kako uporabljati zdravilo Levemir Možni neželeni učinki
There was no clinically relevant difference in pharmacokinetics of Levemir between patients with renal or hepatic impairment and healthy subjects. 
Klinično pomembne razlike v farmakokinetiki zdravila Levemir med bolniki z ledvično ali jetrno okvaro in zdravimi ljudmi niso bile ugotovljene.
Mean HbA1c (%) at GW 36 
Povprečni HbA1c (%) v 36.
Levemir was non-inferior to NPH insulin as measured by HbA1c at gestational week (GW) 36, and the reduction in mean HbA1c through pregnancy was similar, see table 4. 
Zdravilo Levemir je bilo enakovredno insulinu NPH, merjeno s HbA1c v 36. tednu nosečnosti (TN), in znižanje povprečnega HbA1c med nosečnostjo je bilo podobno (glejte preglednico 4).
There are limited data in patients with severe hypoalbuminaemia. 
Pri bolnikih s hudo hipoalbuminemijo ni zadosti podatkov.
Levemir is used to reduce the high blood sugar level in adults, adolescents and children aged 1 year and above with diabetes mellitus (diabetes). 
Zdravilo Levemir se uporablja za znižanje visokega krvnega sladkorja pri odraslih, mladostnikih in otrocih, starih 1 leto in več, s sladkorno boleznijo.